Proceedings of the National Academy of Sciences · 2019 · 16 citations · 33 references
Life SciencesCell BiologyImmunologyCell SignalingInnate ImmunitySignal TransductionInflammatory ProcessesInflammatory SignalingInnate Immune ActivationInnate Immune ResponseInnate Immune Signaling PathwaysToll-like ReceptorsAcute Inflammatory ResponseCellular Inflammatory ResponsesMapk SignalingMitogen-activated Protein Kinase SignalingNuclear Factor Kappa B ActivationToll-like Receptor SignalingToll-like Receptor Signaling PathwaysToll-like Receptor-mediated Innate Immune Response
Significance The NF-ĸB and mitogen-activated protein kinase (MAPK) pathways coordinate the cellular response to most immune stimuli. Toll-like (TLR) and TNF receptor activation of the MAPK pathway requires activation of the TPL-2 kinase. Active TPL-2 is an unstable, short-lived protein, which limits MAPK activity and controls inflammatory responses. Here we report the surprising discovery that active TPL-2 shuttles between the cytoplasm and the nucleus, where it is degraded by the proteasome. BCL-3, a nuclear regulator of NF-ĸB, promotes the nuclear localization and degradation of TPL-2 in order to limit MAPK activity and determines the amount of TLR ligand required to initiate an inflammatory response. Thus, the nucleus is a key site for the integrated regulation of NF-ĸB– and MAPK-driven inflammatory responses.
33